LMTK2

Lemur Tyrosine Kinase 2: A Serine/Threonine Kinase Involved in Endocytosis and Cancer

Gene Information Card

Symbol LMTK2
Full Name Lemur tyrosine kinase 2
Gene Type Protein coding
Chromosomal Location 7q21.3
NCBI Gene ID 22853 ncbi.nlm.nih.gov/gene/22853
Ensembl ID ENSG00000106367
UniProt ID Q8IWU2
OMIM ID 610989
HGNC ID 17880
Aliases KPI-2, LMR2, cprk, PPP1R100, AATYK2

Description

LMTK2 (lemur tyrosine kinase 2) encodes a serine/threonine kinase that belongs to the lemur kinase family. The protein contains an N-terminal kinase domain, a transmembrane domain, and a long cytoplasmic tail. It is involved in endocytic trafficking, regulation of protein phosphatase 1 (PP1), and androgen receptor signaling. LMTK2 is implicated in prostate cancer, Alzheimer disease, and other neurological conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Prostate cancer LMTK2 modulates androgen receptor signaling and endocytosis; loss of function may promote tumor progression OMIM 610989; ClinVar
Alzheimer disease LMTK2 interacts with amyloid precursor protein (APP) and regulates APP trafficking and processing UniProt Q8IWU2; NCBI Gene
Intellectual disability Rare variants in LMTK2 have been associated with neurodevelopmental phenotypes ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Prostate 8.3 Medium
Testis 6.1 Low
Lung 4.7 Low
Kidney 3.9 Low
Cell Line Expression
Cell Line nTPM Notes
PC-3 (prostate cancer) 10.2 Androgen-independent line
LNCaP (prostate cancer) 7.8 Androgen-sensitive line
SH-SY5Y (neuroblastoma) 9.1 Neuronal model
HEK293 (embryonic kidney) 5.4 Common expression model
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.2113C>T (p.Arg705Trp) Missense <0.01% Reported in prostate cancer; functional impact unknown
c.2875C>T (p.Arg959Cys) Missense <0.01% Associated with intellectual disability in ClinVar
c.1234del (p.Leu412Trpfs*5) Frameshift deletion Rare Predicted loss-of-function
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense variants that truncate the kinase domain or C-terminal region are predicted to cause loss of function.

Gain of Function (GOF)

No confirmed gain-of-function mutations have been reported in LMTK2.

Dominant Negative (DN)

No dominant-negative mechanisms have been described for LMTK2.

Gene Ontology (GO)

• protein serine/threonine kinase activity • ATP binding
• protein binding • endocytosis
• protein phosphorylation • regulation of protein phosphatase type 1 activity
• membrane

Pathways

Endocytosis (Reactome R-HSA-199991)
Signaling by Receptor Tyrosine Kinases (Reactome R-HSA-9006934)
Androgen receptor signaling (Reactome R-HSA-5627123)

Protein Summary

LMTK2 is a 1509-amino-acid transmembrane serine/threonine kinase. It localizes to endosomes and the plasma membrane, where it regulates endocytic trafficking by phosphorylating components of the clathrin machinery. It also binds and inhibits protein phosphatase 1 (PP1), thereby modulating phosphorylation-dependent signaling. In neurons, LMTK2 influences APP processing and neurite outgrowth. In prostate cells, it interacts with androgen receptor and may act as a tumor suppressor.

Related Products

Product name Cat.No. Species Gene ID
LMTK2 Knockout HEK293 Cell Line EDJ-KQ3648 Human 22853 Details Get a Quote
LMTK2 Knockout A-549 Cell Line EDJ-KQ25613 Human 22853 Details Get a Quote
LMTK2 Knockout HCT 116 Cell Line EDJ-KQ25614 Human 22853 Details Get a Quote
LMTK2 Knockout HeLa Cell Line EDJ-KQ25615 Human 22853 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: